Regeneron signals beyond the news: 50+ signals from 7 sources
The latest Regeneron signal on this page is from Sep 29, 2026 (Patents): "Regeneron Pharmaceuticals, Inc's patent output is steady: 168 grants in the past year, 15 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (15+) and Patents (12).
Public (REGN)Biotechnology Research10,000+ employeesregeneron.comLinkedIn
- Signals
- 50+
- Sources
- 7
- Last 90 days
- 42
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Regeneron signals by source
50+ signals for Regeneron across 7 sources.
Patents · Patent pace
Regeneron Pharmaceuticals, Inc's patent output is steady: 168 grants in the past year, 15 in the past 30 days.
Over the past year Regeneron Pharmaceuticals, Inc received 168 US patent grants, concentrated in software / computing and image processing / graphics; the recent pace (42 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 168
- Grants, 90 days
- 42
- Grants, 30 days
- 15
- USPTO assignee
- Regeneron Pharmaceuticals, Inc.
Patents · Patent grant
Regeneron was granted a patent for bispecific antibodies targeting tumors.
In September 2026 Regeneron patented antibody treatments designed to direct T cells against cancer cells while limiting unwanted immune activity, for oncology research and therapy.
- Patent title
- Methods and antibody compositions for tumor treatment
- Grant date
- Sep 29, 2026
- Inventors
- Eric Smith, Samuel Davis, Bindu Varghese, Jessica R. Kirshner
Reddit · Customer feedback
A Clinical Research Coordinator who completed two studies with Regeneron praised the company for having a super responsive, accessible, and cooperative team.
Post: "Sponsor/FSP Rankings"
- Subreddit
- r/clinicalresearch
- Upvotes
- 24
- Comments
- 46
- Sentiment
- Positive
Glassdoor · Poor work life balance
Employees report toxic work life balance and long hours despite good benefits
Multiple reviewers mention a toxic work environment and poor work life balance, with some citing longer hours during intense work periods and zero work life balance especially for those required to go into the office.
- Overall rating
- 3.7 of 5
- CEO approval
- 74%
- Reviews read
- 10
- Review window
- Aug 29, 2026 to Sep 8, 2026
Glassdoor · Return to office tension
Mandatory in office days create friction with employees
One employee mentions requiring four days in the office, and another notes zero work life balance especially for those required to go into the office.
- Overall rating
- 3.7 of 5
- CEO approval
- 74%
- Reviews read
- 10
- Review window
- Aug 29, 2026 to Sep 8, 2026
Podcasts · Tech adoption
The MM+M Podcast discusses Regeneron: tech adoption
"Earlier this month, Regeneron debuted Science Illuminated, which is now available on Spotify. The series is born out of the work the New York based drug maker has undertaken across a range of therapies with audio narration and scientific imagery produced by the company's employees."
- Podcast
- The MM+M Podcast
- Episode
- Regeneron’s immersive AV experience reimagines complex science communications
- Speaker
- Bella Joukowsky
- Speaker role
- Third party
Website changes · Community engagement
Regeneron announced that it awarded $150,000 to the winners of the 2026 Regeneron Prize for Creative Innovation.
Added press release: “Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation.”
- Page
- /about/our-company
Podcasts · Sponsorship
Regeneron sponsors The Top Line (house ad)
Welcome to Regeneron's Science Illuminated. Join us as we shine a light on innovation. Bring complexity into focus and pause to appreciate its beauty.
- Podcast
- The Top Line
- Episode
- A genomics library for the AI era
- Paid ad
- Yes
Web traffic · Sustained decline
regeneron.com shows sustained decline with 3 consecutive months of decreases, down 29% overall to 267K.
- Monthly visits
- 267,112
- Month over month
- -24.8%
- 3-month change
- -29.2%
- Global rank
- 154,450
LinkedIn
When promising young scientists are given the opportunity to explore big ideas, extraordinary futures take shape.
When promising young scientists are given the opportunity to explore big ideas, extraordinary futures take shape. For nearly a decade, Regeneron has been the title sponsor of the Science Talent Search (STS), Society for Science’s premier national research competition for high school seniors. Through STS, students...
- Likes
- 67
- Comments
- 1
- Tags
- Research & Development, Learning & Development, Partnership, Corporate Strategy
Showing 10 of 50+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Regeneron with the Signal API
One POST /v1/companies/enrich call with regeneron.com returns Regeneron signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "regeneron.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Regeneron other signals
What signals does Autobound track for Regeneron besides news and filings?
What are people saying about Regeneron online?
What do employees say about working at Regeneron?
Has Regeneron been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .